Goat Milk

Phase 1Small molecule

Goat Milk is one of 8 small molecule programs targeting Allogeneic Hematopoietic Stem Cell Transplant Recipient. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Allogeneic Hematopoietic Stem Cell Transplant RecipientActive, not recruiting

Allogeneic Hematopoietic Stem Cell Transplant RecipientPhase 1

Active, not recruiting

Competition

Competitive Landscape

7 competitors in Allogeneic Hematopoietic Stem Cell Transplant Recipient

#DrugCompanyPhaseTrials

Recombinant Human GM-CSF

EEastern Cooperative Oncology Group

Phase 3

1 2

Shingrix

SShenzhen Shenxin Biotechnology Co., Ltd

Phase 2

1 3

Kepivance

SSwedish Orphan Biovitrum

Phase 1

1 4

Rapamune

PPrism Pharmaceuticals

Phase 1

1 5

Prograf

VVeloxis Pharmaceuticals

Phase 1

1 6

Vepesid

AAvyxa

Phase 1

1 7

Cytoxan

BBaxter Healthcare Corporation

Phase 1

1 8

Goat Milk

CCity of Hope Medical Center

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Active, not recruiting

Allogeneic Hematopoietic Stem Cell Transplant Recipient

NCT04177004

Clinical

Trials by Indication[1]

Stem Cell Transplant1 trial

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Withdrawn·—·Phase 1·NCT03531281

Allogeneic Hematopoietic Stem Cell Transplant Recipient1 trial

A Randomized Pilot Study of Human Lysozyme Goat Milk in Recipients of Standard Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruiting·CCity of Hope Medical Center·Phase 1·NCT04177004·52 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Goat Milk. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Goat Milk compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Goat Milk. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — City of Hope Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: CCity of Hope Medical Center

Goat Milk

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Stem Cell Transplant1 trial

Allogeneic Hematopoietic Stem Cell Transplant Recipient1 trial

References

Drug Info

Quick Facts

Related News